These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7653207)

  • 1. Hemostatic disturbances in acute ischemic stroke: a study of 86 patients.
    Altès A; Abellán MT; Mateo J; Avila A; Martí-Vilalta JL; Fontcuberta J
    Acta Haematol; 1995; 94(1):10-5. PubMed ID: 7653207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations of haemostatic markers in various subtypes and phases of stroke.
    Yamazaki M; Uchiyama S; Maruyama S
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):707-12. PubMed ID: 7507362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of both coagulation and fibrinolysis in childhood hemolytic uremic syndrome.
    Van Geet C; Proesmans W; Arnout J; Vermylen J; Declerck PJ
    Kidney Int; 1998 Oct; 54(4):1324-30. PubMed ID: 9767551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of platelet activation, coagulation, and fibrinolytic activation in patients with symptomatic lacunar stroke.
    Ilhan D; Ozbabalik D; Gulcan E; Ozdemir O; Gülbaçs Z
    Neurologist; 2010 May; 16(3):188-91. PubMed ID: 20445428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Markers of a hypercoagulable state following acute ischemic stroke.
    Takano K; Yamaguchi T; Uchida K
    Stroke; 1992 Feb; 23(2):194-8. PubMed ID: 1561647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coagulation and fibrinolytic system impairment in insulin dependent diabetes mellitus.
    Carmassi F; Morale M; Puccetti R; De Negri F; Monzani F; Navalesi R; Mariani G
    Thromb Res; 1992 Sep; 67(6):643-54. PubMed ID: 1440530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uncoupling of protein C and antithrombin III activity in cerebral ischemia patients associated with cutis marmorata.
    Li TH; Chen TH; Lin HS; Liou CW; Liu JS; Chen SS; Chen WH
    Acta Neurol Taiwan; 2008 Dec; 17(4):233-8. PubMed ID: 19280866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombin activatable fibrinolysis inhibitor and other hemostatic parameters in patients with polycystic ovary syndrome.
    Oral B; Mermi B; Dilek M; Alanoğlu G; Sütçü R
    Gynecol Endocrinol; 2009 Feb; 25(2):110-6. PubMed ID: 19253106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemostatic abnormalities may predict chronic hypertension after preeclampsia.
    Bremme K; Blombäck M
    Gynecol Obstet Invest; 1996; 41(1):20-6. PubMed ID: 8821879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemostatic markers in ischemic stroke of undetermined etiology.
    Ince B; Bayram C; Harmanci H; Ulutin T
    Thromb Res; 1999 Nov; 96(3):169-74. PubMed ID: 10588458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of coagulation and fibrinolytic systems in patients with CLI is not normalized after surgical revascularisation.
    Pärsson H; Holmberg A; Siegbahn A; Bergqvist D
    Eur J Vasc Endovasc Surg; 2004 Feb; 27(2):186-92. PubMed ID: 14718902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemostatic abnormalities in patients with pulmonary embolism compared with that in deep vein thrombosis.
    Yamada N; Wada H; Nakase T; Minamikawa K; Nagaya S; Nakamura M; Hiraoka N; Fuzioka H; Hayashi T; Suzuki K
    Blood Coagul Fibrinolysis; 1995 Oct; 6(7):627-33. PubMed ID: 8562833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma levels of coagulation and fibrinolysis markers in acute ischemic stroke patients with lone atrial fibrillation.
    Topcuoglu MA; Haydari D; Ozturk S; Ozcebe OI; Saribas O
    Neurol Sci; 2000 Aug; 21(4):235-40. PubMed ID: 11214663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the fibrinolytic system in patients with fulminant liver failure.
    Pernambuco JR; Langley PG; Hughes RD; Izumi S; Williams R
    Hepatology; 1993 Dec; 18(6):1350-6. PubMed ID: 8244260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombin III associated with fibrinogen predicts the risk of cerebral ischemic stroke.
    Meng R; Li ZY; Ji X; Ding Y; Meng S; Wang X
    Clin Neurol Neurosurg; 2011 Jun; 113(5):380-6. PubMed ID: 21316837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes of haemostatic parameters in patients with acute cardioembolic stroke].
    Maksimova MIu; Domashenko MA; Ionova VG; Mikhal'chenko VN; Syskina EN; Okhtova FR
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(12 Pt 2):22-7. PubMed ID: 22792744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Level of antithrombin III, protein C, protein S and other selected parameters of coagulation and fibrinolysis in the blood of the patients with recurrent deep venous thrombosis.
    Swiatkiewicz A; Jurkowski P; Kotschy M; Ciecierski M; Jawień A
    Med Sci Monit; 2002 Apr; 8(4):CR263-8. PubMed ID: 11951068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of pre-analytical, demographic, behavioural and metabolic variables on fibrinolysis and haemostasis activation markers utilised to assess hypercoagulability.
    Stegnar M; Cuderman TV; Bozic M
    Clin Chem Lab Med; 2007; 45(1):40-6. PubMed ID: 17243913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-thrombolysis haemostasis changes after rt-PA treatment in acute cerebral infarct. Correlations with cardioembolic aetiology and outcome.
    Sun X; Berthiller J; Derex L; Trouillas P; Diallo L; Hanss M
    J Neurol Sci; 2015 Feb; 349(1-2):77-83. PubMed ID: 25619569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrinolysis, antithrombin III, and protein C in neonates during cardiac operations.
    Petăjă J; Peltola K; Sairanen H; Leijala M; Kekomäki R; Vahtera E; Siimes MA
    J Thorac Cardiovasc Surg; 1996 Sep; 112(3):665-71. PubMed ID: 8800154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.